United States of America
Henry Esber, Ph.D. is the Chairman of the Board since 2012 and has served as a Director since January 2011. Dr. Esber is the Chairperson of the Compensation Committee and is a member of the Audit and Governance and Nominating Committees. In 2000, Dr. Esber co-founded Bio-Quant, Inc. and served as its Senior Vice President and Chief Business Development Officer from 2000-2010. Dr. Esber has over 35 years of experience in the pharmaceutical service industry, including tenures as Executive Director of Business Development at Charles River Laboratories and Director of the Department of Immunology and Clinical Services at TSI Mason. Dr. Esber also served on the Board of Directors of Apricus Biosciences, Inc. (NASDAQ: APRI) and currently serves on the Board of Directors at several privately held pharmaceutical companies.